ENTX
Entera Bio·NASDAQ
--
--(--)
--
--(--)
ENTX fundamentals
Entera Bio (ENTX) released its earnings on Aug 8, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.06 (YoY 0.00%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-0.06
0.00%
Report date
Aug 8, 2025
Earnings Call
7:00 AM on Aug 8, 2025
Meeting link.EPS
Actual | 0.16 | -0.17 | -0.09 | -0.12 | -0.43 | -0.21 | -0.09 | 0.21 | -0.13 | -0.11 | -0.11 | -0.1 | -0.08 | -0.08 | -0.08 | -0.06 | -0.05 | -0.06 | -0.08 | -0.06 | -0.06 | -0.06 | |||||||
Forecast | -0.12 | -0.2 | -0.14 | -0.12 | -0.1233 | -0.115 | -0.2333 | -0.1775 | -0.16 | -0.135 | -0.115 | -0.12 | -0.07 | -0.09 | -0.08 | -0.06 | -0.06 | -0.05 | -0.08 | -0.07 | -0.11 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -41.67% | +55.00% | +14.29% | -258.33% | -70.32% | +21.74% | +190.01% | +26.76% | +31.25% | +18.52% | +13.04% | +33.33% | -14.29% | +11.11% | +25.00% | +16.67% | 0.00% | -60.00% | +25.00% | +14.29% | +45.45% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 42.00K | 52.00K | 50.00K | 200.00K | 157.00K | 109.00K | 140.00K | 161.00K | 68.00K | 51.00K | 8.00K | 14.00K | 13.00K | 14.00K | 0 | 0 | -- | 57.00K | 42.00K | 40.00K | -42.00K | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 91.00K | 173.00K | 120.00K | 127.00K | 178.50K | 100.00K | 70.00K | 90.00K | 100.00K | 0 | 0 | 0 | 0 | 0 | 40.00K | 40.00K | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +72.53% | -36.99% | +16.67% | +26.77% | -61.90% | -49.00% | -88.57% | -84.44% | -87.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +5.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Entera Bio’s earnings call?What is the market's earnings forecast for Entera Bio next quarter?Did Entera Bio beat or miss consensus estimates last quarter?What is Entera Bio's latest dividend and current dividend yield?What does Entera Bio do and what are its main business segments?What factors drove the changes in Entera Bio's revenue and profit?What were the key takeaways from Entera Bio's earnings call?What guidance did Entera Bio's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
